Jump to: navigation, search
Clinical data
ATC code
CAS Number
PubChem CID
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Molar mass188.226
3D model (JSmol)

WikiDoc Resources for Phenazone


Most recent articles on Phenazone

Most cited articles on Phenazone

Review articles on Phenazone

Articles on Phenazone in N Eng J Med, Lancet, BMJ


Powerpoint slides on Phenazone

Images of Phenazone

Photos of Phenazone

Podcasts & MP3s on Phenazone

Videos on Phenazone

Evidence Based Medicine

Cochrane Collaboration on Phenazone

Bandolier on Phenazone

TRIP on Phenazone

Clinical Trials

Ongoing Trials on Phenazone at Clinical

Trial results on Phenazone

Clinical Trials on Phenazone at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Phenazone

NICE Guidance on Phenazone


FDA on Phenazone

CDC on Phenazone


Books on Phenazone


Phenazone in the news

Be alerted to news on Phenazone

News trends on Phenazone


Blogs on Phenazone


Definitions of Phenazone

Patient Resources / Community

Patient resources on Phenazone

Discussion groups on Phenazone

Patient Handouts on Phenazone

Directions to Hospitals Treating Phenazone

Risk calculators and risk factors for Phenazone

Healthcare Provider Resources

Symptoms of Phenazone

Causes & Risk Factors for Phenazone

Diagnostic studies for Phenazone

Treatment of Phenazone

Continuing Medical Education (CME)

CME Programs on Phenazone


Phenazone en Espanol

Phenazone en Francais


Phenazone in the Marketplace

Patents on Phenazone

Experimental / Informatics

List of terms related to Phenazone

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.


Phenazone, or phenazon, is an analgesic. It is formed by reducing diortho-dinitrodiphenyl with sodium amalgam and methyl alcohol, or by heating diphenylene-ortho-dihydrazine with hydrochloric acid to 150 C. It crystallizes in needles which melt at 156 C. Potassium permanganate oxidizes it to pyridazine tetracarboxylic acid.


Analgesine, Antipyrine, Diméthyloxyquinazine, Oxydiméthylquinazine, Oxydiméthylquinizine, Pyrazoline

See also


Chimic Class

  • Pyrazole
  • Pyrazolinone


Adverse effects

  • Allergy to pyrazolones
  • Nausea
  • Agranulocytosis


Cost Effectiveness of Phenazone

| group5 = Clinical Trials Involving Phenazone | list5 = Ongoing Trials on Phenazone at Clinical Trials.govTrial results on PhenazoneClinical Trials on Phenazone at Google

| group6 = Guidelines / Policies / Government Resources (FDA/CDC) Regarding Phenazone | list6 = US National Guidelines Clearinghouse on PhenazoneNICE Guidance on PhenazoneNHS PRODIGY GuidanceFDA on PhenazoneCDC on Phenazone

| group7 = Textbook Information on Phenazone | list7 = Books and Textbook Information on Phenazone

| group8 = Pharmacology Resources on Phenazone | list8 = AND (Dose)}} Dosing of PhenazoneAND (drug interactions)}} Drug interactions with PhenazoneAND (side effects)}} Side effects of PhenazoneAND (Allergy)}} Allergic reactions to PhenazoneAND (overdose)}} Overdose information on PhenazoneAND (carcinogenicity)}} Carcinogenicity information on PhenazoneAND (pregnancy)}} Phenazone in pregnancyAND (pharmacokinetics)}} Pharmacokinetics of Phenazone

| group9 = Genetics, Pharmacogenomics, and Proteinomics of Phenazone | list9 = AND (pharmacogenomics)}} Genetics of PhenazoneAND (pharmacogenomics)}} Pharmacogenomics of PhenazoneAND (proteomics)}} Proteomics of Phenazone

| group10 = Newstories on Phenazone | list10 = Phenazone in the newsBe alerted to news on PhenazoneNews trends on Phenazone

| group11 = Commentary on Phenazone | list11 = Blogs on Phenazone

| group12 = Patient Resources on Phenazone | list12 = Patient resources on PhenazoneDiscussion groups on PhenazonePatient Handouts on PhenazoneDirections to Hospitals Treating PhenazoneRisk calculators and risk factors for Phenazone

| group13 = Healthcare Provider Resources on Phenazone | list13 = Symptoms of PhenazoneCauses & Risk Factors for PhenazoneDiagnostic studies for PhenazoneTreatment of Phenazone

| group14 = Continuing Medical Education (CME) Programs on Phenazone | list14 = CME Programs on Phenazone

| group15 = International Resources on Phenazone | list15 = Phenazone en EspanolPhenazone en Francais

| group16 = Business Resources on Phenazone | list16 = Phenazone in the MarketplacePatents on Phenazone

| group17 = Informatics Resources on Phenazone | list17 = List of terms related to Phenazone